Cargando…

Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012

BACKGROUND: Sulphadoxine-pyrimethamine (SP), an antifolate, was replaced by artemether-lumefantrine as the first-line malaria drug treatment in Kenya in 2004 due to the wide spread of resistance. However, SP still remains the recommended drug for intermittent preventive treatment in pregnant women a...

Descripción completa

Detalles Bibliográficos
Autores principales: Juma, Dennis W, Omondi, Angela A, Ingasia, Luiser, Opot, Benjamin, Cheruiyot, Agnes, Yeda, Redemptah, Okudo, Charles, Cheruiyot, Jelagat, Muiruri, Peninnah, Ngalah, Bidii, Chebon, Lorna J, Eyase, Fredrick, Johnson, Jacob, Bulimo, Wallace D, Akala, Hoseah M, Andagalu, Ben, Kamau, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094641/
https://www.ncbi.nlm.nih.gov/pubmed/24989984
http://dx.doi.org/10.1186/1475-2875-13-250
_version_ 1782325872170106880
author Juma, Dennis W
Omondi, Angela A
Ingasia, Luiser
Opot, Benjamin
Cheruiyot, Agnes
Yeda, Redemptah
Okudo, Charles
Cheruiyot, Jelagat
Muiruri, Peninnah
Ngalah, Bidii
Chebon, Lorna J
Eyase, Fredrick
Johnson, Jacob
Bulimo, Wallace D
Akala, Hoseah M
Andagalu, Ben
Kamau, Edwin
author_facet Juma, Dennis W
Omondi, Angela A
Ingasia, Luiser
Opot, Benjamin
Cheruiyot, Agnes
Yeda, Redemptah
Okudo, Charles
Cheruiyot, Jelagat
Muiruri, Peninnah
Ngalah, Bidii
Chebon, Lorna J
Eyase, Fredrick
Johnson, Jacob
Bulimo, Wallace D
Akala, Hoseah M
Andagalu, Ben
Kamau, Edwin
author_sort Juma, Dennis W
collection PubMed
description BACKGROUND: Sulphadoxine-pyrimethamine (SP), an antifolate, was replaced by artemether-lumefantrine as the first-line malaria drug treatment in Kenya in 2004 due to the wide spread of resistance. However, SP still remains the recommended drug for intermittent preventive treatment in pregnant women and infants (IPT(P/I)) owing to its safety profile. This study assessed the prevalence of mutations in dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes associated with SP resistance in samples collected in Kenya between 2008 and 2012. METHODS: Field isolates collected from Kisumu, Kisii, Kericho and Malindi district hospitals were assessed for genetic polymorphism at various loci within Pfdhfr and Pfdhps genes by sequencing. RESULTS: Among the Pfdhfr mutations, codons N51I, C59R, S108N showed highest prevalence in all the field sites at 95.5%, 84.1% and 98.6% respectively. Pfdhfr S108N prevalence was highest in Kisii at 100%. A temporal trend analysis showed steady prevalence of mutations over time except for codon Pfdhps 581 which showed an increase in mixed genotypes. Triple Pfdhfr N51I/C59R/S108N and double Pfdhps A437G/ K540E had high prevalence rates of 86.6% and 87.9% respectively. The Pfdhfr/Pfdhps quintuple, N51I/C59R/S108N/A437G/K540E mutant which has been shown to be the most clinically relevant marker for SP resistance was observed in 75.7% of the samples. CONCLUSION: SP resistance is still persistently high in western Kenya, which is likely due to fixation of key mutations in the Pfdhfr and Pfdhps genes as well as drug pressure from other antifolate drugs being used for the treatment of malaria and other infections. In addition, there is emergence and increasing prevalence of new mutations in Kenyan parasite population. Since SP is used for IPT(P/I), molecular surveillance and in vitro susceptibility assays must be sustained to provide information on the emergence and spread of SP resistance.
format Online
Article
Text
id pubmed-4094641
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40946412014-07-13 Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012 Juma, Dennis W Omondi, Angela A Ingasia, Luiser Opot, Benjamin Cheruiyot, Agnes Yeda, Redemptah Okudo, Charles Cheruiyot, Jelagat Muiruri, Peninnah Ngalah, Bidii Chebon, Lorna J Eyase, Fredrick Johnson, Jacob Bulimo, Wallace D Akala, Hoseah M Andagalu, Ben Kamau, Edwin Malar J Research BACKGROUND: Sulphadoxine-pyrimethamine (SP), an antifolate, was replaced by artemether-lumefantrine as the first-line malaria drug treatment in Kenya in 2004 due to the wide spread of resistance. However, SP still remains the recommended drug for intermittent preventive treatment in pregnant women and infants (IPT(P/I)) owing to its safety profile. This study assessed the prevalence of mutations in dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes associated with SP resistance in samples collected in Kenya between 2008 and 2012. METHODS: Field isolates collected from Kisumu, Kisii, Kericho and Malindi district hospitals were assessed for genetic polymorphism at various loci within Pfdhfr and Pfdhps genes by sequencing. RESULTS: Among the Pfdhfr mutations, codons N51I, C59R, S108N showed highest prevalence in all the field sites at 95.5%, 84.1% and 98.6% respectively. Pfdhfr S108N prevalence was highest in Kisii at 100%. A temporal trend analysis showed steady prevalence of mutations over time except for codon Pfdhps 581 which showed an increase in mixed genotypes. Triple Pfdhfr N51I/C59R/S108N and double Pfdhps A437G/ K540E had high prevalence rates of 86.6% and 87.9% respectively. The Pfdhfr/Pfdhps quintuple, N51I/C59R/S108N/A437G/K540E mutant which has been shown to be the most clinically relevant marker for SP resistance was observed in 75.7% of the samples. CONCLUSION: SP resistance is still persistently high in western Kenya, which is likely due to fixation of key mutations in the Pfdhfr and Pfdhps genes as well as drug pressure from other antifolate drugs being used for the treatment of malaria and other infections. In addition, there is emergence and increasing prevalence of new mutations in Kenyan parasite population. Since SP is used for IPT(P/I), molecular surveillance and in vitro susceptibility assays must be sustained to provide information on the emergence and spread of SP resistance. BioMed Central 2014-07-02 /pmc/articles/PMC4094641/ /pubmed/24989984 http://dx.doi.org/10.1186/1475-2875-13-250 Text en Copyright © 2014 Juma et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Juma, Dennis W
Omondi, Angela A
Ingasia, Luiser
Opot, Benjamin
Cheruiyot, Agnes
Yeda, Redemptah
Okudo, Charles
Cheruiyot, Jelagat
Muiruri, Peninnah
Ngalah, Bidii
Chebon, Lorna J
Eyase, Fredrick
Johnson, Jacob
Bulimo, Wallace D
Akala, Hoseah M
Andagalu, Ben
Kamau, Edwin
Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title_full Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title_fullStr Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title_full_unstemmed Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title_short Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
title_sort trends in drug resistance codons in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in kenyan parasites from 2008 to 2012
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094641/
https://www.ncbi.nlm.nih.gov/pubmed/24989984
http://dx.doi.org/10.1186/1475-2875-13-250
work_keys_str_mv AT jumadennisw trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT omondiangelaa trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT ingasialuiser trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT opotbenjamin trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT cheruiyotagnes trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT yedaredemptah trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT okudocharles trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT cheruiyotjelagat trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT muiruripeninnah trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT ngalahbidii trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT chebonlornaj trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT eyasefredrick trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT johnsonjacob trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT bulimowallaced trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT akalahoseahm trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT andagaluben trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012
AT kamauedwin trendsindrugresistancecodonsinplasmodiumfalciparumdihydrofolatereductaseanddihydropteroatesynthasegenesinkenyanparasitesfrom2008to2012